TYRA BIOSCIENCES Trademark

Trademark Overview


On Wednesday, May 1, 2024, a trademark application was filed for TYRA BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the TYRA BIOSCIENCES trademark a serial number of 98529313. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 31, 2024. This trademark is owned by Tyra Biosciences, Inc.. The TYRA BIOSCIENCES trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

pharmaceuticals for the treatment of rare genetic diseases; pharmaceuticals for the treatment of musculo-skeletal disorders; pharmaceuticals for the treatment of skeletal dysplasia; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of cells that are resistant to drugs; pharmaceuticals for the treatment and prevention of drug resistance; anti-cancer pharmaceuticals

providing medical information; providing medical information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; Providing a web site featuring medical information; Providing a website featuring information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; providing information in the field of pharmaceuticals; providing medical information in the field of oncology; providing a website featuring information in the field of the diagnosis and treatment of cancer.

Research and development of drugs in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research for medical purposes in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; clinical research in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research and development of pharmaceuticals for the treatment of cancer, rare diseases, musculo-skeletal disorders, and skeletal dysplasia.
tyra biosciences

General Information


Serial Number98529313
Word MarkTYRA BIOSCIENCES
Filing DateWednesday, May 1, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2024

Trademark Statements


Goods and Servicespharmaceuticals for the treatment of rare genetic diseases; pharmaceuticals for the treatment of musculo-skeletal disorders; pharmaceuticals for the treatment of skeletal dysplasia; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of cells that are resistant to drugs; pharmaceuticals for the treatment and prevention of drug resistance; anti-cancer pharmaceuticals
Pseudo MarkTYRA BIO SCIENCES
Goods and Servicesproviding medical information; providing medical information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; Providing a web site featuring medical information; Providing a website featuring information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; providing information in the field of pharmaceuticals; providing medical information in the field of oncology; providing a website featuring information in the field of the diagnosis and treatment of cancer.
NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesResearch and development of drugs in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research for medical purposes in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; clinical research in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research and development of pharmaceuticals for the treatment of cancer, rare diseases, musculo-skeletal disorders, and skeletal dysplasia.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 1, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTyra Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92008

Party NameTyra Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92008

Trademark Events


Event DateEvent Description
Wednesday, May 1, 2024NEW APPLICATION ENTERED
Friday, November 15, 2024ASSIGNED TO EXAMINER
Sunday, October 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 6, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, December 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 6, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 6, 2024EXAMINER'S AMENDMENT ENTERED
Friday, December 6, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, December 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 31, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED